Skip to main content
. 2019 Jan 22;11:931–941. doi: 10.2147/CMAR.S183355

Table 1.

Relationship between LIPH expression and clinicopathological characteristics in TCGA cohort

Characteristics Expression of LIPH, n (%)
P-value
Low (n=252) High (n=252)

Age at diagnosis
Mean ± SD 48.34±16.20 46.17±15.43 0.126
<45 years 110 (43.7) 119 (47.2) 0.421
≥45 years 142 (56.3) 133 (52.8)
Gender 0.547
Female 181 (71.8) 187 (74.2)
Male 71 (28.2) 65 (25.8)
Histological type <0.001***
Classical 153 (60.7) 204 (81.0)
Other specified 99 (39.3) 48 (19.0)
Tumor size
Mean ± SD 2.99±1.76 2.81±1.58 0.235
≤2 cm 85 (35.3) 86 (36.8) 0.736
>2 cm 156 (64.7) 148 (63.2)
T stage 0.213
T1 77 (30.8) 65 (25.8)
>T1 173 (69.2) 187 (74.2)
Unilateral or bilateral 0.236
Unilateral 214 (84.9) 204 (81.0)
Bilateral 38 (15.1) 48 (19.0)
Multifocal or unifocal 0.588
Multifocal 110 (44.5) 116 (47.0)
Unifocal 137 (55.5) 131 (53.0)
Extrathyroidal invasion <0.001***
Yes 53 (22.0) 100 (40.8)
No 188 (78.0) 145 (59.2)
Lymph-node metastasis <0.001***
Yes 82 (37.3) 142 (60.7)
No 138 (62.7) 92 (39.3)
Metastasis 0.252
M0 130 (94.9) 150 (98.0)
M1 7 (5.1) 3 (2.0)
AJCC disease stage 0.023*
I + II 180 (71.7) 156 (62.2)
III + IV 71 (28.3) 95 (37.8)

Note:

*

P<0.05,

***

P<0.001.

Abbreviations: AJCC, American Joint Committee on Cancer; LIPH, lipase H; TCGA, The Cancer Genome Atlas.